Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ecovyst Inc.ECVT · Entity 4897 | See Remarks | August 04, 2022 | August 08, 2022 |
| Livent Corp.LTHM · Entity 95365 | Vice President and COO | March 01, 2019 | March 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ecovyst Inc.
Report date August 04, 2022 · Filed August 08, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 343,532.693 |
Reported balance
After 2022-08-04 transaction · row 1
1 source rowRow 1 · 2022-08-04 · Purchase · Acquired 11,389.693 · Balance 343,532.693 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.75 to $8.79, inclusive. The reporting person undertakes to provide to Ecovyst Inc., any security holder of Ecovyst Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.75 to $8.79, inclusive. The reporting person undertakes to provide to Ecovyst Inc., any security holder of Ecovyst Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Livent Corp.
Report date March 01, 2019 · Filed March 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 71,683 |
Reported balance
After 2019-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-03-01 · Grant · Acquired 38,300 · Balance 71,683 F1: Represents the grant of restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), upon the conversion of restricted stock units with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent and FMC ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019 ("Record Date"). F2: The Livent RSUs were granted pursuant to the Livent Corporation Incentive Compensation and Stock Plan ("Livent Plan") in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting and payment schedules) as applicable to the corresponding FMC restricted stock units. F3: Reflects shares of Livent Common Stock received in connection with the Distribution in respect of the shares of FMC Common Stock held as of the Record Date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.29 · Expires 2027-02-27 | Direct | 41,389 |
Reported balance
After 2019-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-01 · Grant · Acquired 41,389 · Balance 41,389 F4: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.26 · Expires 2028-02-15 | Direct | 25,253 |
Reported balance
After 2019-03-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-01 · Grant · Acquired 25,253 · Balance 25,253 F4: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), upon the conversion of restricted stock units with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent and FMC ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019 ("Record Date").
F2: The Livent RSUs were granted pursuant to the Livent Corporation Incentive Compensation and Stock Plan ("Livent Plan") in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting and payment schedules) as applicable to the corresponding FMC restricted stock units.
F3: Reflects shares of Livent Common Stock received in connection with the Distribution in respect of the shares of FMC Common Stock held as of the Record Date.
F4: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 04, 2022 Filed Aug 8, 2022 20:28 UTC | Ecovyst Inc. ECVT · Entity 4897 | PurchaseCommon Stock | 11,389.693 | $8.78 | $100,000.37 |
DisclosureSEC source: 0000899243-22-027990 · doc4.xml · nonDerivative · entry 1 Schneberger Thomas · CIK 0001752725 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 343,532.693 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.75 to $8.79, inclusive. The reporting person undertakes to provide to Ecovyst Inc., any security holder of Ecovyst Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| May 20, 2022 Filed May 23, 2022 20:30 UTC | Ecovyst Inc. ECVT · Entity 4897 | PurchaseCommon Stock | 5,000 | $9.86 | $49,296.50 |
DisclosureSEC source: 0000899243-22-019210 · doc4.xml · nonDerivative · entry 1 Schneberger Thomas · CIK 0001752725 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,143 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.85 to $9.86, inclusive. The reporting person undertakes to provide to Ecovyst Inc., any security holder of Ecovyst Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| January 17, 2022 Filed Jan 19, 2022 21:24 UTC | Ecovyst Inc. ECVT · Entity 4897 | GrantCommon Stock | 145,773 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-002411 · doc4.xml · nonDerivative · entry 2 Schneberger Thomas · CIK 0001752725 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 327,143 Read SEC document |
| January 17, 2022 Filed Jan 19, 2022 21:24 UTC | Ecovyst Inc. ECVT · Entity 4897 | GrantCommon Stock, par value $0.01 per share ("Common Stock") | 72,887 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-002411 · doc4.xml · nonDerivative · entry 1 Schneberger Thomas · CIK 0001752725 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,370 Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 21:30 UTC | Ecovyst Inc. ECVT · Entity 4897 | Tax withholdingCommon Stock | 1,090 | $10.27 | $11,194.30 |
DisclosureSEC source: 0000899243-22-001368 · doc4.xml · nonDerivative · entry 1 Schneberger Thomas · CIK 0001752725 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,483 Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:18 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 25,253 | Not disclosed Strike: $12.26 | Not disclosed |
DisclosureSEC source: 0000950103-19-003078 · dp103211_4-schneberger.xml · derivative · entry 3 Schneberger Thomas · CIK 0001752725 · Vice President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,253 Underlying: Common Stock · 25,253 shares Expires 2028-02-15 F4 · shares: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. F4 · price: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:18 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (Right to Buy) · Derivative | 41,389 | Not disclosed Strike: $8.29 | Not disclosed |
DisclosureSEC source: 0000950103-19-003078 · dp103211_4-schneberger.xml · derivative · entry 2 Schneberger Thomas · CIK 0001752725 · Vice President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,389 Underlying: Common Stock · 41,389 shares Expires 2027-02-27 F4 · shares: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. F4 · price: Represents the grant of stock options to purchase Livent Common Stock ("Livent Options") upon the conversion of stock options to purchase FMC Common Stock ("FMC Options"), in accordance with the terms of the EMA and the anti-dilution adjustment provisions under the FMC Plan, in connection with the Distribution. The Livent Options were granted pursuant to the Livent Plan in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting, exercise and expiration schedules) as applicable to the corresponding FMC Options. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 16:18 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 38,300 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-19-003078 · dp103211_4-schneberger.xml · nonDerivative · entry 1 Schneberger Thomas · CIK 0001752725 · Vice President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,683 F1 · shares: Represents the grant of restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), upon the conversion of restricted stock units with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent and FMC ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019 ("Record Date"). F2 · shares: The Livent RSUs were granted pursuant to the Livent Corporation Incentive Compensation and Stock Plan ("Livent Plan") in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting and payment schedules) as applicable to the corresponding FMC restricted stock units. F1 · price: Represents the grant of restricted stock units ("Livent RSUs") with respect to shares of common stock of Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), upon the conversion of restricted stock units with respect to shares of common stock of FMC Corporation ("FMC"), par value $0.10 per share ("FMC Common Stock"), held by the Reporting Person as of March 1, 2019, in accordance with the terms of the Amended and Restated Employee Matters Agreement, dated as of February 4, 2019, by and between Livent and FMC ("EMA") and the anti-dilution adjustment provisions under the FMC Incentive Compensation and Stock Plan ("FMC Plan"), in connection with the prorata spinoff distribution ("Distribution") by FMC of all of its shares of Livent Common Stock to the holders of record of FMC Common Stock on February 25, 2019 ("Record Date"). F2 · price: The Livent RSUs were granted pursuant to the Livent Corporation Incentive Compensation and Stock Plan ("Livent Plan") in a manner intended to preserve the aggregate intrinsic value of the awards, and are generally subject to the same terms and conditions (including vesting and payment schedules) as applicable to the corresponding FMC restricted stock units. F3 · balance_after: Reflects shares of Livent Common Stock received in connection with the Distribution in respect of the shares of FMC Common Stock held as of the Record Date. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 16:22 UTC | Livent Corp. LTHM · Entity 95365 | GrantStock Option (right to purchase) · Derivative | 85,715 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0000950103-18-011973 · dp96876_4-schneberger.xml · derivative · entry 2 Schneberger Thomas · CIK 0001752725 · Vice President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,715 Underlying: Common Stock · 85,715 shares Expires not disclosed F2 · shares: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Plan. The stock options are scheduled to vest and become exercisable 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. F2 · derivative.exercise_date: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Plan. The stock options are scheduled to vest and become exercisable 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. F2 · derivative.expiration_date: Reflects the grant of stock options to purchase shares of common stock of the Issuer under the Plan. The stock options are scheduled to vest and become exercisable 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. The stock options will expire on the tenth anniversary of the date of grant. Read SEC document |
| October 10, 2018 Filed Oct 12, 2018 16:22 UTC | Livent Corp. LTHM · Entity 95365 | GrantCommon Stock | 26,471 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-18-011973 · dp96876_4-schneberger.xml · nonDerivative · entry 1 Schneberger Thomas · CIK 0001752725 · Vice President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,471 F1 · shares: Reflects the grant of restricted stock units under the Issuer's Incentive Compensation and Stock Plan (the "Plan"), which are scheduled to vest 50% on each of the third and fourth anniversaries of the date of grant, subject to the terms of the Plan and the applicable award agreement issued thereunder. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.